Anasvitae: Dosing, Side Effect & Interaction

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Concise Prescribing Info

Contents

Anastrozole

Indications/Uses

Hormone receptor +ve advanced breast cancer in postmenopausal women. Adjuvant treatment of hormone receptor +ve early invasive breast cancer in postmenopausal women & those who have received 2-3 yr of adjuvant tamoxifen.

Click to view Anasvitae detailed prescribing information

Dosage/Direction for Use

Adult including elderly 1 tab once daily. Postmenopausal women w/ hormone receptor +ve early invasive breast cancer Recommended duration of adjuvant endocrine treatment: 5 yr.

Click to view Anasvitae detailed prescribing information

Overdosage

View Anasvitae overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Pregnancy or lactation.

Click to view Anasvitae detailed prescribing information

Special Precautions

Not to be used in premenopausal women. Increased risk of fracture due to reduction in bone mineral density. Assess bone mineral density at start of treatment & at regular intervals in women w/ or at risk of osteoporosis. Carefully monitor & initiate appropriate treatment or prophylaxis for osteoporosis. Avoid concomitant use w/ tamoxifen or estrogen-containing therapies. Not to be taken by patients w/ galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. May affect ability to drive & operate machinery. Moderate or severe hepatic & severe renal impairment. Not to be used in boys & girls w/ growth hormone deficiency in addition to growth hormone treatment. Not recommended for use in childn & adolescents.

Click to view Anasvitae detailed prescribing information

Use In Pregnancy & Lactation

Click to view Anasvitae detailed prescribing information

Adverse Reactions

Headache; hot flushes; nausea; rash; arthralgia/joint stiffness, arthritis, osteoporosis; asthenia. Anorexia, hypercholesterolaemia; somnolence, carpal tunnel syndrome, sensory disturbances (including paraesthesia, taste loss & perversion); diarrhoea, vomiting; increased alkaline phosphatase, ALT & AST; hair thinning (alopecia), allergic reactions; bone pain, myalgia; vag dryness & bleeding. SJS.

Click to view Anasvitae detailed prescribing information

Drug Interactions

Diminished pharmacological action w/ tamoxifen or estrogen-containing therapies.

Click to view Anasvitae detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Anasvitae detailed prescribing information

Storage

View Anasvitae storage conditions for details to ensure optimal shelf-life.

Description

View Anasvitae description for details of the chemical structure and excipients (inactive components).

Action

View Anasvitae mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cancer Hormone Therapy

ATC Classification

L02BG03 - anastrozole ; Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.

Thai FDA Category

Presentation/Packing

Form

Anasvitae FC tab 1 mg

Packing/Price

1 × 28's

Anasvitae

anastrozole

Manufacturer:

SAG Manufacturing

Distributor:

Pacific Healthcare